Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33425 | 125 | 42.7 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
140 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY | 23462 |
33425 | 1 | ARTIFICIAL ANTIGEN PRESENTING CELLS//ANTIGEN SPECIFIC CD8T CELLS//HLA A2 IG | 125 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ARTIFICIAL ANTIGEN PRESENTING CELLS | authKW | 1034602 | 10% | 35% | 12 |
2 | ANTIGEN SPECIFIC CD8T CELLS | authKW | 488569 | 2% | 100% | 2 |
3 | HLA A2 IG | authKW | 488569 | 2% | 100% | 2 |
4 | HLA IG DIMER | authKW | 488569 | 2% | 100% | 2 |
5 | LARGE MULTIVALENT IMMUNOGEN VACCINE | authKW | 488569 | 2% | 100% | 2 |
6 | PMDC11 | authKW | 488569 | 2% | 100% | 2 |
7 | LEUKEMIC PLASMACYTOID DENDRITIC CELL LINE | authKW | 439710 | 2% | 60% | 3 |
8 | PARACRINE DELIVERY | authKW | 439710 | 2% | 60% | 3 |
9 | DIFFUSIVE INTERACTIONS | authKW | 325711 | 2% | 67% | 2 |
10 | PMDC05 | authKW | 325711 | 2% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 858 | 40% | 0% | 50 |
2 | Oncology | 298 | 26% | 0% | 33 |
3 | Medicine, Research & Experimental | 127 | 13% | 0% | 16 |
4 | Hematology | 71 | 8% | 0% | 10 |
5 | Biochemical Research Methods | 45 | 7% | 0% | 9 |
6 | Materials Science, Biomaterials | 40 | 3% | 0% | 4 |
7 | Cell Biology | 35 | 10% | 0% | 13 |
8 | Nanoscience & Nanotechnology | 33 | 6% | 0% | 8 |
9 | Biotechnology & Applied Microbiology | 23 | 7% | 0% | 9 |
10 | Engineering, Biomedical | 14 | 3% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIBODY VACCINE GRP MP88CANC SCI UNIT | 244285 | 1% | 100% | 1 |
2 | CURE VECTOR CORE | 244285 | 1% | 100% | 1 |
3 | CURE VECTOR CORE JCCC VECTOR SHARED OURCE FA | 244285 | 1% | 100% | 1 |
4 | CYTOKINES CANC | 244285 | 1% | 100% | 1 |
5 | DEV GENES HUMAN DIS EDUC MINIST | 244285 | 1% | 100% | 1 |
6 | HLTH SCI EXPT IMMUNOL | 244285 | 1% | 100% | 1 |
7 | JCCC VECTOR SHARED OURCE IL | 244285 | 1% | 100% | 1 |
8 | JULIA MCFARLANE DIABET JMDRC | 244285 | 1% | 100% | 1 |
9 | LEONARD M MILLE MED | 244285 | 1% | 100% | 1 |
10 | LMMUNOBIOL INTERNAL MED | 244285 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING | 1694 | 1% | 1% | 1 |
2 | JOURNAL OF IMMUNOLOGICAL METHODS | 1614 | 6% | 0% | 8 |
3 | CLINICAL IMMUNOLOGY | 1458 | 3% | 0% | 4 |
4 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 1401 | 4% | 0% | 5 |
5 | CELLULAR & MOLECULAR IMMUNOLOGY | 1189 | 2% | 0% | 2 |
6 | TRENDS IN MOLECULAR MEDICINE | 791 | 2% | 0% | 2 |
7 | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 759 | 2% | 0% | 2 |
8 | JOURNAL OF IMMUNOTHERAPY | 578 | 2% | 0% | 2 |
9 | CANCER IMMUNOLOGY RESEARCH | 542 | 1% | 0% | 1 |
10 | NANOMATERIALS | 505 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ARTIFICIAL ANTIGEN PRESENTING CELLS | 1034602 | 10% | 35% | 12 | Search ARTIFICIAL+ANTIGEN+PRESENTING+CELLS | Search ARTIFICIAL+ANTIGEN+PRESENTING+CELLS |
2 | ANTIGEN SPECIFIC CD8T CELLS | 488569 | 2% | 100% | 2 | Search ANTIGEN+SPECIFIC+CD8T+CELLS | Search ANTIGEN+SPECIFIC+CD8T+CELLS |
3 | HLA A2 IG | 488569 | 2% | 100% | 2 | Search HLA+A2+IG | Search HLA+A2+IG |
4 | HLA IG DIMER | 488569 | 2% | 100% | 2 | Search HLA+IG+DIMER | Search HLA+IG+DIMER |
5 | LARGE MULTIVALENT IMMUNOGEN VACCINE | 488569 | 2% | 100% | 2 | Search LARGE+MULTIVALENT+IMMUNOGEN+VACCINE | Search LARGE+MULTIVALENT+IMMUNOGEN+VACCINE |
6 | PMDC11 | 488569 | 2% | 100% | 2 | Search PMDC11 | Search PMDC11 |
7 | LEUKEMIC PLASMACYTOID DENDRITIC CELL LINE | 439710 | 2% | 60% | 3 | Search LEUKEMIC+PLASMACYTOID+DENDRITIC+CELL+LINE | Search LEUKEMIC+PLASMACYTOID+DENDRITIC+CELL+LINE |
8 | PARACRINE DELIVERY | 439710 | 2% | 60% | 3 | Search PARACRINE+DELIVERY | Search PARACRINE+DELIVERY |
9 | DIFFUSIVE INTERACTIONS | 325711 | 2% | 67% | 2 | Search DIFFUSIVE+INTERACTIONS | Search DIFFUSIVE+INTERACTIONS |
10 | PMDC05 | 325711 | 2% | 67% | 2 | Search PMDC05 | Search PMDC05 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | EGGERMONT, LJ , PAULIS, LE , TEL, J , FIGDOR, CG , (2014) TOWARDS EFFICIENT CANCER IMMUNOTHERAPY: ADVANCES IN DEVELOPING ARTIFICIAL ANTIGEN-PRESENTING CELLS.TRENDS IN BIOTECHNOLOGY. VOL. 32. ISSUE 9. P. 456 -465 | 29 | 34% | 16 |
2 | SHEN, CL , CHENG, K , MIAO, SW , WANG, W , HE, Y , MENG, FY , ZHANG, JQ , (2013) LATEX BEAD-BASED ARTIFICIAL ANTIGEN-PRESENTING CELLS INDUCE TUMOR-SPECIFIC CTL RESPONSES IN THE NATIVE T-CELL REPERTOIRES AND INHIBIT TUMOR GROWTH.IMMUNOLOGY LETTERS. VOL. 150. ISSUE 1-2. P. 1-11 | 14 | 52% | 7 |
3 | TURTLE, CJ , RIDDELL, SR , (2010) ARTIFICIAL ANTIGEN-PRESENTING CELLS FOR USE IN ADOPTIVE IMMUNOTHERAPY.CANCER JOURNAL. VOL. 16. ISSUE 4. P. 374-381 | 20 | 28% | 26 |
4 | LABOWSKY, M , LOWENTHAL, J , FAHMY, TM , (2015) AN IN SILICOANALYSIS OF NANOPARTICLE/CELL DIFFUSIVE TRANSFER: APPLICATION TO NANO-ARTIFICIAL ANTIGEN-PRESENTING CELL:T-CELL INTERACTION.NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. VOL. 11. ISSUE 4. P. 1019 -1028 | 12 | 38% | 0 |
5 | SUNSHINE, JC , PERICA, K , SCHNECK, JP , GREEN, JJ , (2014) PARTICLE SHAPE DEPENDENCE OF CD8+T CELL ACTIVATION BY ARTIFICIAL ANTIGEN PRESENTING CELLS.BIOMATERIALS. VOL. 35. ISSUE 1. P. 269-277 | 12 | 31% | 26 |
6 | VAN DER WEIJDEN, J , PAULIS, LE , VERDOES, M , VAN HEST, JCM , FIGDOR, CG , (2014) THE RIGHT TOUCH: DESIGN OF ARTIFICIAL ANTIGEN-PRESENTING CELLS TO STIMULATE THE IMMUNE SYSTEM.CHEMICAL SCIENCE. VOL. 5. ISSUE 9. P. 3355 -3367 | 21 | 21% | 3 |
7 | KOSMIDES, AK , MEYER, RA , HICKEY, JW , AJE, K , CHEUNG, KN , GREEN, JJ , SCHNECK, JP , (2017) BIOMIMETIC BIODEGRADABLE ARTIFICIAL ANTIGEN PRESENTING WITH PD-1 BLOCKADE TO TREAT MELANOMA CELLS SYNERGIZE.BIOMATERIALS. VOL. 118. ISSUE . P. 16 -26 | 11 | 38% | 0 |
8 | MEYER, RA , SUNSHINE, JC , PERICA, K , KOSMIDES, AK , AJE, K , SCHNECK, JP , GREEN, JJ , (2015) BIODEGRADABLE NANOELLIPSOIDAL ARTIFICIAL ANTIGEN PRESENTING CELLS FOR ANTIGEN SPECIFIC T-CELL ACTIVATION.SMALL. VOL. 11. ISSUE 13. P. 1519 -1525 | 10 | 37% | 4 |
9 | SHEN, CL , HE, Y , CHENG, K , ZHANG, DP , MIAO, SW , ZHANG, AF , MENG, FY , MIAO, FQ , ZHANG, JQ , (2011) KILLER ARTIFICIAL ANTIGEN-PRESENTING CELLS DEPLETE ALLOANTIGEN-SPECIFIC T CELLS IN A MURINE MODEL OF ALLOSKIN TRANSPLANTATION.IMMUNOLOGY LETTERS. VOL. 138. ISSUE 2. P. 144-155 | 12 | 32% | 9 |
10 | SHEN, C , ZHANG, J , XIA, L , MENG, F , XIE, W , (2007) INDUCTION OF TUMOR ANTIGEN-SPECIFIC CYTOTOXIC T CELL RESPONSES IN NAIVE MICE BY LATEX MICROSPHERES-BASED ARTIFICIAL ANTIGEN-PRESENTING CELL CONSTRUCTS.CELLULAR IMMUNOLOGY. VOL. 247. ISSUE 1. P. 28-35 | 9 | 41% | 3 |
Classes with closest relation at Level 1 |